SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of May 2012
Commission File Number 000-20181
Sapiens International Corporation N.V.
(translation of registrant’s name into English)
c/o Landhuis Joonchi
Kaya Richard J. Beaujon z/n
P.O. Box 837
Willemstad,
Curaçao
(599) (9) 7366277
(address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F
Form 20-F S Form 40-F £
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): £
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): £
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934
Yes £ No S
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
Sapiens Q1 2012 Revenue nearly doubled year over year reaching $26 Million
Non-GAAP Net Income Grows 63% to $3.2 Million;
REHOVOT, Israel, May 8, 2012 -- Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces its financial results for the first quarter ended March 31, 2012.
First Quarter 2012 Highlights Include:
Commenting on the first quarter results, Roni Al Dor, President and CEO of Sapiens International, "The first quarter was a good start for Sapiens, as we begin our first full year following the acquisitions of IDIT and FIS. Our revenue grew by 95%, non-GAAP net income & non-GAPP operating profit both increased 63.0%. We will continue to improve the operational efficiencies of the newly acquired entities and expand the margins, as we have done many times in the past, with other companies, including Sapiens itself.
As a global provider of insurance solutions, with new products, geographical coverage and channels to sell in to, we are very encouraged about our opportunities for growth. We are seeing high demand for our products in North America, and have increased our staff by 30 employees in the last quarter due to demand from customers. Compounding our growth prospects are the market dynamics, insurance companies shifting its information technology (IT) spend to external providers.”
Mr. Al Dor continued, “We reiterate our guidance for 2012 to grow revenue in excess of $100 million.”
Reconciliation between U.S. GAAP and Non-GAAP results is summarized in the following table. For a complete reconciliation, please refer to the tables at the end of this release.
-2- |
(U.S. Dollars in thousands, except per share amounts)
For the three months ended | ||||||||
U.S GAAP basis | 3/31/2012 | 3/31/2011 | ||||||
(Unaudited) | (Unaudited) | |||||||
Revenues | 25,983 | 13,325 | ||||||
Operating profit | 2,441 | 1,720 | ||||||
Net income attributable to Sapiens | 2,388 | 1,673 | ||||||
Basic earnings per share | 0.06 | 0.08 | ||||||
Diluted earnings per share | 0.06 | 0.07 | ||||||
Non-GAAP | ||||||||
Revenues | 25,983 | 13,325 | ||||||
Operating profit | 3,308 | 2,034 | ||||||
Net income attributable to Sapiens | 3,211 | 1,963 | ||||||
Basic earnings per share | 0.08 | 0.09 | ||||||
Diluted earnings per share | 0.08 | 0.08 |
First Quarter 2012 Results
Revenue for the first quarter of 2012 was $26.0 million, compared to $13.3 million for the first quarter of 2011; an increase of 95%. Net income attributable to Sapiens on a GAAP basis was $2.4 million for the first quarter of 2012, compared to net income of $1.7 million for the first quarter of 2011. EPS was $0.06 per diluted share for the first quarter of 2012 compared to $0.07 per diluted share for the first quarter of 2011. GAAP operating income was $2.4 million for the first quarter of 2012, compared to $1.7 million for the first quarter of 2011.
Non-GAAP net income attributable to Sapiens for the first quarter of 2012 totaled $3.2 million, compared to non-GAAP net income of $2.0 million for the first quarter of 2011. Non-GAAP EPS was $0.08 per diluted share for the first quarter of 2012, compared to $0.08 per diluted share for the first quarter of 2011. Non-GAAP operating income was $3.3 million for the three months ended March 31, 2012, compared to $2.0 million in the same period last year.
About Sapiens International
Sapiens International Corporation (NASDAQ and TASE: SPNS), is a leading global provider of innovative business solutions for the insurance industry, helping to modernize business processes, to proactively define and provide innovative new services and to respond quickly to changes in the industry. We offer end to end solutions for the L&P, P&C and Reinsurance markets, with customers across the globe. We jointly serve over 70 insurance customers, backed by a team of over 700 insurance experts. Coupled with our financial stability, Sapiens aims to become the vendor of choice in the insurance software marketplace. For more information about Sapiens, visit http://www.sapiens.com.
Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of accounting policies, specific system configurations and software needs of individual customers and other risk factors.
Investor
Relations Contact:
Roni Giladi, CFO
Sapiens International
Tel: +972-8-9382721
E-mail: roni.g@sapiens.com
or
James Carbonara, Regional Vice President
Hayden IR
Office: (646)-755-7412
James@haydenir.com
-3- |
SAPIENS INTERNATIONAL CORPORATION N.V. | ||||
Condensed Consolidated Balance Sheets | ||||
(U.S. Dollars in thousands) | ||||
3/31/2012 | 12/31/2011 | |||||||
(Unaudited) | (Audited) | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 27,093 | $ | 21,460 | ||||
Restricted cash | 464 | 456 | ||||||
Trade receivables, net | 18,953 | 14,484 | ||||||
Other current assets | 3,476 | 3,229 | ||||||
Total current assets | 49,986 | 39,629 | ||||||
Property and equipment, net | 1,767 | 1,814 | ||||||
Other assets, net | 113,740 | 112,025 | ||||||
Total assets | $ | 165,493 | $ | 153,468 | ||||
Liabilities and shareholders' equity | ||||||||
Trade payables | $ | 2,530 | $ | 2,559 | ||||
Other liabilities and accrued expenses | 18,019 | 19,731 | ||||||
Deferred revenue | 17,271 | 9,603 | ||||||
Total current liabilities | 37,820 | 31,893 | ||||||
Long-term debt and other long-term liabilities | 11,591 | 11,328 | ||||||
Equity | 116,082 | 110,247 | ||||||
Total liabilities and equity | $ | 165,493 | $ | 153,468 |
-4- |
SAPIENS INTERNATIONAL CORPORATION N.V. | ||||
Condensed Consolidated Statements of Operations | ||||
(U.S. Dollars in thousands, except per share amounts) | ||||
For the three months ended | ||||||||
3/31/2012 | 3/31/2011 | |||||||
Unaudited | Unaudited | |||||||
Revenues | $ | 25,983 | $ | 13,325 | ||||
Cost of revenues | $ | 15,157 | $ | 7,125 | ||||
Gross Profit | 10,826 | 6,200 | ||||||
Operating expenses | ||||||||
Research and development, net | $ | 2,300 | $ | 1,060 | ||||
Selling, marketing, general and administrative | $ | 6,085 | $ | 3,420 | ||||
Operating Profit | 2,441 | 1,720 | ||||||
Financial expenses (income), net | $ | (61 | ) | $ | 41 | |||
Other expenses, net | $ | 108 | $ | 6 | ||||
Net Income | $ | 2,393 | $ | 1,673 | ||||
Attributetable to non-controlling interest | $ | 5 | $ | — | ||||
Net income attributable to Sapiens | $ | 2,388 | $ | 1,673 | ||||
Earnings per share | ||||||||
Basic | $ | 0.06 | $ | 0.08 | ||||
Diluted | $ | 0.06 | $ | 0.07 | ||||
Weighted average number of shares used to computation of earnings per share | ||||||||
Basic | 39,719 | 21,602 | ||||||
Diluted | 42,401 | 23,199 |
-5- |
SAPIENS INTERNATIONAL CORPORATION N.V. | ||||||
Reconciliation of GAAP to Non-GAAP results | ||||||
(U.S. Dollars in thousands, except per share amounts) | ||||||
For the three months ended | ||||||||
3/31/2012 | 3/31/2011 | |||||||
(Unaudited) | (Unaudited) | |||||||
GAAP operating profit | 2,441 | 1,720 | ||||||
Amortization of intangibles assets and compensation related to acquisition | 863 | 294 | ||||||
Amortization of capitalized software | 834 | 1,090 | ||||||
Capitalization of software development | (980 | ) | (1,155 | ) | ||||
Stock-based compensation | 150 | 85 | ||||||
Total adjustments to GAAP | 867 | 314 | ||||||
Non-GAAP operating profit | 3,308 | 2,034 | ||||||
GAAP net income | 2,388 | 1,673 | ||||||
Total adjustments to GAAP as above | 867 | 314 | ||||||
Non-controlling interest in amortization intangible assets | (24 | ) | — | |||||
Deferred taxes related to acquisition | (20 | ) | (24 | ) | ||||
Non-GAAP net income | 3,211 | 1,963 | ||||||
Non-GAAP basic earnings per share | 0.08 | 0.09 | ||||||
Non-GAAP diluted earnings per share | 0.08 | 0.08 | ||||||
Weighted average number of shares used to computation of earnings per share | ||||||||
Basic | 39,719 | 21,602 | ||||||
Diluted | 42,401 | 23,199 |
-6- |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Sapiens International Corporation N.V. | ||
(Registrant) | ||
Date: May 8, 2012 | By: | /s/ Roni Giladi |
Roni Giladi | ||
Chief Financial Officer |
-7- |